These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 9833423)

  • 1. [Familial cyclic neutropenia].
    Shinozaki K; Komiyama A
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):46-9. PubMed ID: 9833423
    [No Abstract]   [Full Text] [Related]  

  • 2. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mathematical model of haemopoiesis as exemplified by CD34 cell mobilization into the peripheral blood.
    Obeyesekere MN; Berry RW; Spicer PP; Korbling M
    Cell Prolif; 2004 Aug; 37(4):279-94. PubMed ID: 15245564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defects of granulopoiesis in patients with severe congenital neutropenia.
    Nakamura K; Kobayashi M; Konishi N; Kawaguchi H; Miyagawa S; Sato T; Katoh O; Ueda K
    Hiroshima J Med Sci; 2002 Sep; 51(3):63-74. PubMed ID: 12422946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.
    Bashey A; Donohue M; Liu L; Medina B; Corringham S; Ihasz A; Carrier E; Castro JE; Holman PR; Xu R; Law P; Ball ED; Lane TA
    Transfusion; 2007 Nov; 47(11):2153-60. PubMed ID: 17958545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cyclic neutropenia].
    Huizinga T; Janssens A; van Kersen F; Weening RS
    Ned Tijdschr Geneeskd; 1986 Feb; 130(7):311-3. PubMed ID: 3951636
    [No Abstract]   [Full Text] [Related]  

  • 7. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo.
    Gutschalk CM; Herold-Mende CC; Fusenig NE; Mueller MM
    Cancer Res; 2006 Aug; 66(16):8026-36. PubMed ID: 16912178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
    Meng FY; Xu B; Sun J; Yang Y; Niu JN
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1051-2. PubMed ID: 15447861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
    J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical symptoms and neutropenia: the balance of neutrophil development, functional activity, and cell death.
    Kuijpers TW
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S75-82. PubMed ID: 12373577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly efficient gene transfer into preterm CD34 hematopoietic progenitor cells.
    Shields LE; Kiem HP; Andrews RG
    Am J Obstet Gynecol; 2000 Sep; 183(3):732-7. PubMed ID: 10992201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cyclic neutropenia].
    Ohara A
    Ryoikibetsu Shokogun Shirizu; 2000; (32):163-5. PubMed ID: 11212676
    [No Abstract]   [Full Text] [Related]  

  • 14. Granulocyte and granulocyte macrophage colony-stimulating factors as therapy in human and veterinary medicine.
    Fernández-Varón E; Villamayor L
    Vet J; 2007 Jul; 174(1):33-41. PubMed ID: 17029990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion.
    Möhle R; Kanz L
    Semin Hematol; 2007 Jul; 44(3):193-202. PubMed ID: 17631183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells.
    Obermueller E; Vosseler S; Fusenig NE; Mueller MM
    Cancer Res; 2004 Nov; 64(21):7801-12. PubMed ID: 15520186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-macrophage-colony-stimulating factor in established febrile neutropenia.
    Mitchell PL; Pinkerton CR
    J Clin Oncol; 1999 Sep; 17(9):3002. PubMed ID: 10561379
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [G-CSF versus GM-CSF in the treatment of neutropenia in a patient with Felty's syndrome on hemodialysis].
    del Pozo C; Ortiz de Salazar MI; Torregrosa I; Sánchez L; Albero MD; Bauza J
    Nefrologia; 2000; 20(5):455-8. PubMed ID: 11100668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.